[HTML][HTML] Multi-inflammatory syndrome in children (MIS-C) in 2023: is it time to forget about it?
F La Torre, A Taddio, C Conti, M Cattalini - Children, 2023 - mdpi.com
Multisystem inflammatory syndrome in children (MIS-C) is defined as a clinically serious
condition requiring hospitalization involving fever, multi-system organ dysfunction, and an …
condition requiring hospitalization involving fever, multi-system organ dysfunction, and an …
[HTML][HTML] Cardiac involvement in patients with multisystem inflammatory syndrome in children (MIS-C) in Poland
KM Ludwikowska, N Moksud, P Tracewski, M Sokolski… - Biomedicines, 2023 - mdpi.com
Multisystem inflammatory syndrome in children (MIS-C) is an immune-mediated
complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
[HTML][HTML] Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives
YK Sun, C Wang, PQ Lin, L Hu, J Ye, ZG Gao… - World Journal of …, 2024 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) tends to have mild
presentations in children. However, severe and critical cases do arise in the pediatric …
presentations in children. However, severe and critical cases do arise in the pediatric …
[HTML][HTML] A genetically modulated Toll-like-receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome
Dysregulated innate immune responses contribute to multisystem inflammatory syndrome in
children (MIS-C), characterized by gastrointestinal, mucocutaneous, and/or cardiovascular …
children (MIS-C), characterized by gastrointestinal, mucocutaneous, and/or cardiovascular …
[HTML][HTML] Leitlinie S1 für das Management postviraler Zustände am Beispiel Post-COVID-19
S Rabady, K Hoffmann, M Aigner, J Altenberger… - Wiener klinische …, 2023 - Springer
Die vorliegende Leitlinie S1 ist die Aktualisierung und Weiterentwicklung der Leitlinie S1
Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Sie fasst den Stand der …
Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Sie fasst den Stand der …
[HTML][HTML] Programmed Cell Death Protein-1 Regulation in Response to SARS-CoV-2 in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with …
V Opoka-Winiarska, E Grywalska… - International Journal of …, 2024 - mdpi.com
The role of programmed death cell protein 1 (PD-1) has already been described in a range
of various diseases, including COVID-19. This study provides new, innovative data, related …
of various diseases, including COVID-19. This study provides new, innovative data, related …
Treatment of multisystem inflammatory syndrome in children
T Tong, YH Jin, M Wang, FQ Gong - World Journal of Pediatrics, 2024 - Springer
Background Multisystem inflammatory syndrome in children (MIS-C), a relatively uncommon
but severe pediatric complication, is associated with coronavirus disease 2019 (COVID-19) …
but severe pediatric complication, is associated with coronavirus disease 2019 (COVID-19) …
[HTML][HTML] Multisystem inflammatory syndrome in children
A Mauro, T Giani - Frontiers in Pediatrics, 2024 - frontiersin.org
Multisystem inflammatory syndrome is a severe complication associated with COVID-19,
initially recognized as a distinct clinical entity in 2020 (1). In a bulletin from the UK's National …
initially recognized as a distinct clinical entity in 2020 (1). In a bulletin from the UK's National …
Serological analysis of severe acute respiratory syndrome coronavirus 2 infection in children with Kawasaki disease
Y Kondo, Y Kawamura, F Hattori… - Journal of Medical …, 2023 - Wiley Online Library
Multisystem inflammatory syndrome in children (MIS‐C) was reported as a severe
complication of coronavirus disease 2019; an infection with severe acute respiratory …
complication of coronavirus disease 2019; an infection with severe acute respiratory …
S1 guidelines for the management of postviral conditions using the example of post-COVID-19
S Rabady, K Hoffmann, M Aigner… - Wiener Klinische …, 2023 - europepmc.org
Die vorliegende Leitlinie S1 ist die Aktualisierung und Weiterentwicklung der Leitlinie S1
Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Sie fasst den Stand der …
Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Sie fasst den Stand der …